Dr. Hoots is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6410 Fannin St
Ste 500
Houston, TX 77030Phone+1 832-325-7111Fax+1 713-512-2227
Education & Training
- University of North Carolina HospitalsResidency, Pediatrics, 1979 - 1980
- University of Texas Southwestern Medical CenterResidency, Pediatrics, 1975 - 1978
- University of North Carolina at Chapel Hill School of MedicineClass of 1975
- University of North Carolina HospitalsFellowship, Pediatric Hematology/Oncology
Certifications & Licensure
- NC State Medical License 1977 - 2025
- TX State Medical License 1980 - 2025
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
Publications & Presentations
PubMed
- 227 citationsThe scoring system of the Scientific and Standardisation Committee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis...Cheng Hock Toh, W. K. Hoots
Journal of Thrombosis and Haemostasis. 2007-03-01 - 10 citationsAggressive combination therapy in the successful management of life-threatening intracranial hemorrhage in a patient with idiopathic thrombocytopenic purpura.William Keith Hoots, Diane Huntington, Dana V. Devine, Cecilia Schmidt, Arthur Bracey
The American Journal of Pediatric Hematology/oncology. 1986-01-01 - 163 citationsStimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer.Saroj Vadhan-Raj, L J Murray, Carlos E. Bueso-Ramos, Shreyaskumar Patel, Saraswati P. Reddy
Annals of Internal Medicine. 1997-05-01
Press Mentions
- Research Shows U.S. Ability to Treat Patients Who Require Blood on Any Given Day in PerilMarch 1st, 2024
Grant Support
- Underlying Genetic Predisposition In Children For Future Adverse ClottingNational Center For Research Resources2000
- Hemophilia Growth And Development StudyNational Center For Research Resources1996–2000
- ACTG 302--Virologic Response To New Nucleosides After ZDV Or DDI MonotherapyNational Center For Research Resources1996
- ACTG 196--Prevention Of Mycobacterium Avium Compex In HIV+ PatientsNational Center For Research Resources1996
- ACTG 193a--Treatment Of Advanced HIV Disease In Patients With Prior TreatmentNational Center For Research Resources1996
- ACTG 175--Monotherapy VS Combination Therapy In HIV+ Persons With CD4 = 200-500National Center For Research Resources1996
- ACT 303--Influence Of Risk Status On Response To Antiretroviral InterventionNational Center For Research Resources1996
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: